Depo-Provera Linked to Brain Tumors

Publish Date : 11/04/2024

Recent studies and FDA reports have linked Pfizer’s Depo-Provera birth control shot, containing medroxyprogesterone acetate (MPA), to an increased risk of developing meningioma brain tumors. Despite Depo-Provera’s long-standing reputation as a safe contraceptive, a March 2024 BMJ study found women using the shot for one year or longer had a 5.5 times higher risk of meningioma.

Case reports submitted to the FDA since the 2000s have indicated serious outcomes for some Depo-Provera users, including hospitalizations and permanent disabilities. Plaintiffs claim Pfizer did not adequately warn about the risk. Lawyers are now investigating potential lawsuits on behalf of affected women, with free case evaluations available.